Walleye Capital’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Walleye Capital's RMD Position: Q3 2026 in Review
Walleye Capital reduced its ResMed (RMD) stake by 90% in Q3 2026, selling an estimated $16.6M and leaving 8,766 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2862.
Walleye Capital first reported a position in RMD in Q2 2019 and has held it in 13 quarters since. The position peaked at $16.6M in Q2 2026. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Walleye Capital held 8,766 shares of ResMed worth $1.94M as of Q3 2026.
- Walleye Capital sold 76,179 ResMed shares in Q3 2026, an estimated $16.6M.
- ResMed made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2862 holding.
- Walleye Capital first reported a position in ResMed in Q2 2019 and has held it in 13 quarters since.
- Walleye Capital's ResMed position peaked at $16.6M in Q2 2026.
- 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.